Diethylpropion: Formerly marketed for short-term (12 weeks) weight loss as Tenuate/Tepanil. EMA recommended withdrawal in 2022 due to pulmonary hypertension and valvular heart disease risk. Functions as prodrug to ethcathinone, a preferential norepinephrine releaser with weaker dopaminergic activity
Related pages